Adars and the balance game between virus infection and innate immune cell response

Current Issues in Molecular Biology

Volumn 17, Issue 1, 2015, Pages 37-52

  Tomaselli, Sara ^a   Galeano, Federica ^a   Locatelli, Franco ^a,b   Gallo, Angela ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE DEAMINASES ACTING ON DOUBLE STRANDED RNA; ADENOSINE DEAMINASES ACTING ON DOUBLE STRANDED RNA 1; ADENOSINE DEAMINASES ACTING ON DOUBLE STRANDED RNA 1 P110; ADENOSINE DEAMINASES ACTING ON DOUBLE STRANDED RNA 1 P150; ADENOSINE DEAMINASES ACTING ON DOUBLE STRANDED RNA 2; BETA INTERFERON; DOUBLE STRANDED RNA; GAG PROTEIN; GUANOSINE; I KAPPA B KINASE EPSILON; INITIATION FACTOR 2; INOSINE; INTERFERON REGULATORY FACTOR 3; KAPOSIN A; MESSENGER RNA; MICRORNA; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 4; PROTEIN KINASE R; PROTEIN P15; RETINOBLASTOMA PROTEIN; RIBONUCLEOPROTEIN; RNA DIRECTED DNA POLYMERASE; SINGLE STRANDED RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ARENAVIRIDAE; ARTICLE; AVIAN LEUKOSIS ONCOVIRUS; BOVINE VIRAL DIARRHEA VIRUS; BUNYAVIRIDAE; CELLULAR DISTRIBUTION; DENGUE VIRUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME MODIFICATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FLAVIVIRIDAE; GENE CONTROL; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HERPESVIRIDAE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN METAPNEUMOVIRUS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNE RESPONSE; INFLUENZA A; INFLUENZA VIRUS A; INNATE IMMUNITY; KAPOSI SARCOMA; LIFE CYCLE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEASLES VIRUS; MURINE POLYOMA VIRUS; NONHUMAN; ORTHOMYXOVIRUS; PARAINFLUENZA VIRUS 3; PARAMYXOVIRIDAE; POLYOMA VIRUS; POLYOMAVIRUS INFECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RETROVIRUS; RHABDOVIRIDAE; RIFT VALLEY FEVER VIRUS; RNA BINDING; RNA DEGRADATION; RNA EDITING; RNA SPLICING; RNA STRUCTURE; RNA TRANSCRIPTION; RNA TRANSLATION; ROUS ASSOCIATED VIRUS TYPE 1; SEQUENCE ANALYSIS; SIMIAN T CELL LEUKEMIA VIRUS TYPE 3; TRANSLATION INITIATION; VESICULOVIRUS; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION; ANIMAL; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; RNA VIRUS; VIRUS DISEASES;

ADENOSINE DEAMINASE; ANIMALS; GENOME, VIRAL; HUMANS; IMMUNITY, INNATE; RNA EDITING; RNA VIRUSES; RNA, VIRAL; VIRUS DISEASES;

EID: 84922418223     PISSN: 14673037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (120)

1. Alisi, A., Tomaselli, S., Balsano, C., and Gallo, A. (2011). Hepatitis C virus therapeutics: editing enzymes promising therapeutic targets? Hepatology 54, 742; author reply 742–743.
2. Arias, C., Weisburd, B., Stern-Ginossar, N., Mercier, A., Madrid, A.S., Bellare, P., Holdorf, M., Weissman, J.S., and Ganem, D. (2014). KSHV 2.0: A Comprehensive Annotation of the Kaposi's Sarcoma-Associated Herpesvirus Genome Using Next-Generation Sequencing Reveals Novel Genomic and Functional Features. PLoS Pathog. 10, e1003847.
3. Balachandran, S., and Barber, G.N. (2000). Vesicular stomatitis virus (VSV) therapy of tumors. IUBMB life 50, 135–138.
4. Barre-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., et al.(1983). Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868–871.
5. Bass, B.L., and Weintraub, H. (1988). An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 55, 1089–1098.
6. Becher, P., and Thiel, H.J. (2002). Genus Pestivirus (Flaviviridae). In The Springer index of viruses (Tidona, C.A., and Darai, G., eds.), pp 327–331, Springer-Verlag, Heidelberg.
7. Billeter, M.A., Cattaneo, R., Spielhofer, P., Kaelin, K., Huber, M., Schmid, A., Baczko, K., and ter Meulen, V. (1994). Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis. Ann. N.Y. Acad. Sci. 724, 367–377.
8. Biswas, N., Wang, T., Ding, M., Tumne, A., Chen, Y., Wang, Q., and Gupta, P. (2012). ADAR1 is a novel multi targeted anti-HIV-1 cellular protein. Virology 422, 265-277.
9. Carpenter, J.A., Keegan, L.P., Wilfert, L., O'Connell, M.A., and Jiggins, F.M. (2009). Evidence for ADAR-induced hypermutation of the Drosophila sigma virus (Rhabdoviridae). BMC genetics 10, 75.
10. Casey, J.L. (2006). RNA editing in hepatitis delta virus. Curr. Top. Microbiol. Immunol. 307, 67–89.
11. Cathomas, G. (2003). Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus. Herpes 10, 72–77.
12. Cattaneo, R., Schmid, A., Billeter, M.A., Sheppard, R.D., and Udem, S.A. (1988a). Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line. J. Virol. 62, 1388–1397.
13. Cattaneo, R., Schmid, A., Eschle, D., Baczko, K., ter Meulen, V., and Billeter, M.A. (1988b). Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55, 255-265.
14. Chang, F.L., Chen, P.J., Tu, S.J., Wang, C.J., and Chen, D.S. (1991). The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus. Proc. Natl. Acad. Sci. U.S.A. 88, 8490–8494.
15. Chen, P.J., Chang, F.L., Wang, C.J., Lin, C.J., Sung, S.Y., and Chen, D.S. (1992). Functional study of hepatitis delta virus large antigen in packaging and replication inhibition: role of the amino-terminal leucine zipper. J. Virol. 66, 2853–2859.
16. Choo, Q.L., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W., and Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359–362.
17. Choo, Q.L., Richman, K.H., Han, J.H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Medina-Selby, R., Barr, P.J., et al.(1991). Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 88, 2451–2455.
18. Clement, S., Pascarella, S., and Negro, F. (2009). Hepatitis C virus infection: molecular pathways to steatosis, insulin resistance and oxidative stress. Viruses 1, 126–143.
19. Clerzius, G., Gelinas, J.F., Daher, A., Bonnet, M., Meurs, E.F., and Gatignol, A. (2009). ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication. J. Virol. 83, 10119–10128.
20. Clerzius, G., Gelinas, J.F., and Gatignol, A. (2011). Multiple levels of PKR inhibition during HIV-1 replication. Rev. Med. Virol. 21, 42–53.
21. Clerzius, G., Shaw, E., Daher, A., Burugu, S., Gélinas, J.F., Ear, T., Sinck, L., Routy, J.P., Mouland, A.J., Patel, R.C., et al.(2013). The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication. Retrovirology 10, 96.
22. Collins, P.L., McIntosh, K., and Chanock, R.M. (1996). Respiratory Syncytial Virus. In Fields Virology (Fields, B.N., Knipe, D.M., and Howley. P.M., eds), 3rd edn, pp 1313–1351, Lippincott-Raven, Philadelphia.
23. Cullen, B.R. (2009). Viral and cellular messenger RNA targets of viral microRNAs. Nature 457, 421–425.
24. Damania, B. (2004). Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis. Nat. Rev. 2, 656–668.
25. de Chassey, B., Aublin-Gex, A., Ruggieri, A., Meyniel-Schicklin, L., Pradezynski, F., Davoust, N., Chantier, T., Tafforeau, L., Mangeot, P.E., Ciancia, C., et al. (2013). The interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replication. PLoS Pathog. 9, e1003440.
26. Doria, M., Neri, F., Gallo, A., Farace, M.G., and Michienzi, A. (2009). Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. Nucleic Acids Res. 37, 5848–5858.
27. Doria, M., Tomaselli, S., Neri, F., Ciafre, S.A., Farace, M.G., Michienzi, A., and Gallo, A. (2011). The ADAR2 editing enzyme is a novel Hiv-1 proviral factor. J. Gen. Virol. 92, 1228–1232.
28. Felder, M.P., Laugier, D., Yatsula, B., Dezelee, P., Calothy, G., and Marx, M. (1994). Functional and biological properties of an avian variant long terminal repeat containing multiple A to G conversions in the U3 sequence. J. Virol. 68, 4759–4767.
29. Finke, S., Cox, J.H., and Conzelmann, K.K. (2000). Differential transcription attenuation of rabies virus genes by intergenic regions: generation of recombinant viruses overexpressing the polymerase gene. J. Virol. 74, 7261-7269.
30. Franze-Fernandez, M.T., Zetina, C., Iapalucci, S., Lucero, M.A., Bouissou, C., Lopez, R., Rey, O., Daheli, M., Cohen, G.N., and Zakin, M.M. (1987). Molecular structure and early events in the replication of Tacaribe arenavirus S RNA. Virus Res. 7, 309–324.
31. Gale, M.Jr., and Katze, M.G. (1998). Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78, 29-46.
32. Gallo, A., and Locatelli, F. (2011). ADARs: allies or enemies? The importance of A-to-I RNA editing in human disease: from cancer to HIV-1. Biol. Rev. Camb. Philos. Soc. 87, 95–110.
33. Gallo, R.C., Sarin, P.S., Gelmann, E.P., Robert-Guroff, M., Richardson, E., Kalyanaraman, V.S., Mann, D., Sidhu, G.D., Stahl, R.E., Zolla-Pazner, S., et al.(1983). Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 220, 865–867.
34. Gandy, S.Z., Linnstaedt, S.D., Muralidhar, S., Cashman, K.A., Rosenthal, L.J., and Casey, J.L. (2007). RNA editing of the human herpesvirus 8 kaposin transcript eliminates its transforming activity and is induced during lytic replication. J. Virol. 81, 13544–13551.
35. Garcia, M.A., Gil, J., Ventoso, I., Guerra, S., Domingo, E., Rivas, C., and Esteban, M. (2006). Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 70, 1032–1060.
36. George, C.X., and Samuel, C.E. (2011). Host response to polyomavirus infection is modulated by RNA adenosine deaminase ADAR1 but not by ADAR2. J. Virol. 85, 8338-8347.
37. George, C.X., Li, Z., Okonski, K.M., Toth, A.M., Wang, Y., and Samuel, C.E. (2009). Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products. J. Interferon. Cytokine Res. 29, 477–487.
38. Gog, J.R., Afonso Edos, S., Dalton, R.M., Leclercq, I., Tiley, L., Elton, D., von Kirchbach, J.C., Naffakh, N., Escriou, N., and Digard, P. (2007). Codon conservation in the influenza A virus genome defines RNA packaging signals. Nucleic Acids Res. 35, 1897–1907.
39. Gu, R., Zhang, Z., and Carmichael, G.G. (2006). How a small DNA virus uses dsRNA but not RNAi to regulate its life cycle. Cold Spring Harb. Symp. Quant. Biol. 71, 293-299.
40. Gu, R., Zhang, Z., DeCerbo, J.N., and Carmichael, G.G. (2009). Gene regulation by sense–antisense overlap of polyadenylation signals. RNA 15, 1154–1163.
41. Hajjar, A.M., and Linial, M.L. (1995). Modification of retroviral RNA by double-stranded RNA adenosine deaminase. J. Virol. 69, 5878–5882.
42. Hyde-DeRuyscher, R., and Carmichael, G.G. (1988). Polyomavirus early-late switch is not regulated at the level of transcription initiation and is associated with changes in RNA processing. Proc. Natl. Acad. Sci. U.S.A. 85, 8993–8997.
43. Iglesias N.G., and Gamarnik, A.V. (2011). Dynamic RNA structures in the dengue virus genome. RNA Biol. 8, 249–257.
44. Iizasa, H., Wulff, B.E., Alla, N.R., Maragkakis, M., Megraw, M., Hatzigeorgiou, A., Iwakiri, D., Takada, K., Wiedmer, A., Showe, L., et al.(2010). Editing of Epstein–Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J. Biol. Chem. 285, 33358–33370.
45. Ito, T., Tahara, S.M., and Lai, M.M. (1998). The 3'-untraslated region of hepatitis C virus RNA enhances translation from an internal ribosomal entry site. J. Virol. 72, 783–786.
46. Jayan, G.C., and Casey, J.L. (2002a). Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2. J. Virol. 76, 3819–3827.
47. Jayan, G.C., and Casey, J.L. (2002b). Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression. J. Virol. 76, 12399–12404.
48. Jayan, G.C., and Casey, J.L. (2005). Effects of conserved RNA secondary structures on hepatitis delta virus genotype I RNA editing, replication, and virus production. J. Virol. 79, 11187–11193.
49. John, L., and Samuel, C.E. (2014). Induction of stress granules by interferon and down-regulation by the cellular RNA adenosine deaminase ADAR1. Virology 454–455, 299–310.
50. Ko, N.L., Birlouez, E., Wain-Hobson, S., Mahieux, R., and Vartanian, J.P. (2012). Hyperediting of human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 by the dsRNA adenosine deaminase ADAR-1. J. Gen. Virol. 93, 2646–2651.
51. Kumar, M., and Carmichael, G.G. (1997). Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts. Proc. Natl. Acad. Sci. U.S.A. 94, 3542–3547.
52. Kuo, M.Y., Chao, M., and Taylor, J. (1989). Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J. Virol. 63, 1945–1950.
53. Lei, T., Yuen, K., Tsao, S.W., Chen, H., Kok, K., and Jin, D. (2013). Perturbation of biogenesis and targeting of Epstein-Barr virus-encoded miR-BART3 microRNA by adenosine-to-inosine editing. J. Gen. Virol. 94, 2739-2744.
54. Lemaire, P.A., Anderson, E., Lary, J., and Cole, J.L. (2008). Mechanism of PKR Activation by dsRNA. J. Mol. Biol. 381, 351–360.
55. Levrero, M. (2006). Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25, 3834–3847.
56. Li, Y., Masaki, T., Shimakami, T., and Lemon, S.M. (2014). hnRNP L and NF90 interact with hepatitis C virus 5'-terminal untraslated RNA and promote efficient replication. J. Virol. 88, 7199–7209.
57. Li, Z., Okonski, K.M., and Samuel, C.E. (2012). Adenosine deaminase acting on RNA 1 (ADAR1) supresses the induction of interferon by measles virus. J. Gen. Virol. 86, 3787–3794.
58. Li, Z., Wolff, K.C., and Samuel, C.E. (2010). RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment. Virology 396, 316–322.
59. Liao, J., Thakur, S.A., Zalinger, Z.B., Gerrish, K.E., and Imani, F. (2011). Inosine-containing RNA is a novel innate immune Recognition element and reduces RSV infection. PLoS One 6, e26463.
60. Lindenbach, B.D., and Rice, C.M. (2001). Flaviviridae: the viruses and their replication. In Fields Virology (Fields, B.N., Knipe, D.M., and Howley. P.M., eds), 4th edn, pp 991–1042, Lippincott-Raven, Philadelphia.
61. Liu, Z., and Carmichael, G.G. (1993). Polyoma virus early-late switch: regulation of late RNA accumulation by DNA replication. Proc. Natl. Acad. Sci. U.S.A. 90, 8494–8498.
62. Liu, Z., and Carmichael, G.G. (1994). Nuclear antisense RNA. An efficient new method to inhibit gene expression. Mol. Biotechnol. 2, 107–118.
63. Martinez, I., and Melero, J.A. (2002). A model for the generation of multiple A to G transitions in the human respiratory syncytial virus genome: predicted RNA secondary structures as substrates for adenosine deaminases that act on RNA. J. Gen. Virol. 83, 1445-1455.
64. Martinez, I., Dopazo, J., and Melero, J.A. (1997). Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. Gen, J.. Virol. 78 (Pt10), 2419–2429.
65. Meurs, E., Chong, K., Galabru, J., Thomas, N.S., Kerr, I.M., Williams, B.R., and Hovanessian, A.G. (1990). Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62, 379–390.
66. Mohamed, Y.M., Bangphoomi, N., Yamane, D., Suda, Y., Kato, K., Horimoto, T., and Akashi, H. (2014). Physical interaction between bovine viral diarrhea virus nonstructural protein 4A and adenosine deaminase acting on RNA (ADAR). Arch. Virol. 159, 1735–1741.
67. Muralidhar, S., Pumfery, A.M., Hassani, M., Sadaie, M.R., Kishishita, M., Brady, J.N., Doniger, J., Medveczky, P., and Rosenthal, L.J. (1998). Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J. Virol. 72, 4980–4988.
68. Muralidhar, S., Veytsmann, G., Chandran, B., Ablashi, D., Doniger, J., and Rosenthal, L.J. (2000). Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12). J. Clin. Virol. 16, 203–213.
69. Murphy, D.G., Dimock, K., and Kang, C.Y. (1991). Numerous transitions in human parainfluenza virus 3 RNA recovered from persistently infected cells. Virology 181, 760–763.
70. Neumann, G., Chen, H., Gao, G.F., Shu, Y., and Kawaoka, Y. (2009). H5N1 influenza viruses: outbreaks and biological properties. Cell Res. 20, 51–61.
71. Nie, Y., Ding, L., Kao, P.N., Braun, R., and Yang, J.H. (2005). ADAR1 interacts with NF90 through doublestranded RNA and regulates NF90-mediated gene expression independently of RNA editing. Mol. Cell. Biol. 25, 6956–6963.
72. Nie, Y., Hammond, G.L., and Yang, J.H. (2007). Double stranded RNA deaminase ADAR1 increases host susceptibility to virus infection. J. Virol. 81, 917–923.
73. O’Hara, P.J., Nichol, S.T., Horodyski, F.M., and Holland, J.J. (1984). Vesicular stomatitis virus defective interfering particles can contain extensive genomic sequence rearrangements and base substitutions. Cell 36, 915-924.
74. Ohsaki, E., and Ueda, K. (2012). Kaposi's sarcomaassociated Herpesvirus genome replication, partitioning, and maintenance in latency. Front. Microbiol. 3, 7.
75. Okonski, K.M., and Samuel, C.E. (2013). Stress granule formation induced by measles virus is protein kinase PKR dependent and impaired by RNA adenosine deaminase ADAR1. J. Gen. Virol. 87, 756–766.
76. Oldstone, M.B. (2009). Modeling subacute sclerosing panencephalitis in a transgenic mouse system: uncoding pathogenesis of disease and illuminating components of immune control. Curr. Top. Microbiol. Immunol. 330, 31-54.
77. Papa, A., Dalla, V., Petala, A., Maltezou, H.C., and Maltezos, E. (2010). Fatal Mediterranean spotted fever in Greece. Clin. Microbiol. Infect. 16, 589–592.
78. Patel, R.C., and Sen, G.C. (1998). PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 17, 4379–4390.
79. Patel, C.V., Handy, I., Goldsmith, T. and Patel, R.C. (2000). PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J. Biol. Chem. 275, 37993–37998.
80. Patterson, J.B., and Samuel, C.E. (1995). Expression and regulation by interferon of a double-stranded-RNAspecific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol. Cell. Biol. 15, 5376–5388.
81. Patterson, J.B., Cornu, T.I., Redwine, J., Dales, S., Lewicki, H., Holz, A., Thomas, D., Billeter, M.A., and Oldstone, M.B. (2001). Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease. Virology 291, 215–225.
82. Pettersson, R.F., and von Bonsdorff, C.H. (1975). Ribonucleoproteins of Uukuniemi virus are circular. J. Virol. 15, 386–392.
83. Pfaller, C.K., Li, Z., George, C.X., and Samuel, C.E. (2011). Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response. Curr. Opin. Immunol. 23, 573–582.
84. Pfeffer, S., Sewer, A., Lagos-Quintana, M., Sheridan, R., Sander, C., Grasser, F.A., van Dyk, L.F., Ho, C.K., Shuman, S., Chien, M., et al.(2005). Identification of microRNAs of the herpesvirus family. Nat. Methods 2, 269–276.
85. Phuphuakrat, A., Kraiwong, R., Boonarkart, C., Lauhakirti, D., Lee, T.H., and Auewarakul, P. (2008). Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins. J. Virol. 82, 10864–10872.
86. Polson, A.G., Bass, B.L., and Casey, J.L. (1996). RNA editing of hepatitis delta virus antigenome by dsRNAadenosine deaminase. Nature 380, 454–456.
87. Raza, S.A., Clifford, G.M., and Franceschi, S. (2007). Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br. J. Cancer 96, 1127–1134.
88. Rice, C. M. (1996). Flaviviridae: the viruses and their replication. In Fields Virology (Fields, B.N., Knipe, D.M., and Howley. P.M., eds), 3rd edn, pp 931–960, Lippincott-Raven, Philadelphia.
89. Romeo, R., Del Ninno, E., Rumi, M., Russo, A., Sangiovanni, A., de Franchis, R., Ronchi, G., and Colombo, M. (2009). A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology 136, 1629-1638.
90. Rueda, P., Garcia-Barreno, B., and Melero, J.A. (1994). Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations). Virology 198, 653–662.
91. Sadler, A.J., and Williams, B.R. (2007). Structure and function of the protein kinase R. Curr. Top. Microbiol. Immunol. 316, 253–292.
92. Sadler, R., Wu, L., Forghani, B., Renne, R., Zhong, W., Herndier, B., and Ganem, D. (1999). A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73, 5722–5730.
93. Samuel, C.E. (2011). Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology 411, 180–193.
94. Satterly, N., Tsai, P.L., van Deursen, J., Nussenzveig, D.R., Wang, Y., Faria, P.A., Levay, A., Levy, D.E., and Fontoura, B.M. (2007). Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc. Natl. Acad. Sci. U.S.A. 104, 1853–1858.
95. Seufi, A.M., and Galal, F.H. (2010). Role of Culex and Anopheles mosquito species as potential vectors of rift valley fever virus in Sudan outbreak, 2007. BMC Infect. Dis. 10, 65.
96. Sharmeen, L., Bass, B., Sonenberg, N., Weintraub, H., and Groudine, M. (1991). Tat-dependent adenosine-to-inosine modification of wild-type transactivation response RNA. Proc. Natl. Acad. Sci. U.S.A. 88, 8096–8100.
97. Simmonds, P. (2004). Genetic diversity and evolution of hepatitis C virus -15 years on. J. Gen. Virol. 85, 3173-3188.
98. Singh, M., Patel, R.C. (2012). Increased interaction between PACT molecules in response to stress signals is required for PKR activation. J. Cell. Biochem. 113, 2754-2764.
99. Skalsky, R.L., and Cullen, B.R. (2010). Viruses, microRNAs, and host interactions. Annu. Rev. Microbiol. 64, 123–141.
100. Slattery, J.P., Franchini, G. and Gessain, A. (1999). Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res. 9, 525-540.
101. Stojdl, D.F., Abraham, N., Knowles, S., Marius, R., Brasey, A., Lichty, B.D., Brown, E.G., Sonenberg, N., and Bell, J.C. (2000). The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J. Virol. 74, 9580–9585.
102. Suspene, R., Renard, M., Henry, M., Guetard, D., Puyraimond-Zemmour, D., Billecocq, A., Bouloy, M., Tangy, F., Vartanian, J.P., and Wain-Hobson, S. (2008). Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs. Nucleic Acids Res. 36, e72.
103. Suspene, R., Petit, V., Puyraimond-Zemmour, D., Aynaud, M.M., Henry, M., Guetard, D., Rusniok, C., Wain-Hobson, S., and Vartanian, J.P. (2011). Double-stranded RNA adenosine deaminase ADAR-1-induced hypermutated genomes among inactivated seasonal influenza and live attenuated measles virus vaccines. J. Virol. 85, 2458-2462.
104. Talbot, S.J., and Crawford, D.H. (2004). Viruses and tumours-an update. Eur. J. Cancer 40, 1998–2005.
105. Taylor, D.R., Puig, M., Darnell, M.E., Mihalik, K., and Feinstone, S.M. (2005). New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J. Virol. 79, 6291–6298.
106. tenOever, B.R., Ng, S.L., Chua, M.A., McWhirter, S.M., Garcia-Sastre, A., and Maniatis, T. (2007). Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315, 1274–1278.
107. Tomaselli, S., Locatelli, F. and Gallo, A. (2014). The RNA editing enzymes ADARs: mechanism of action and human disease. Cell Tissue Res. 356:527-532.
108. Toth, A.M., Li, Z., Cattaneo, R., and Samuel, C.E. (2009). RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR. J. Biol. Chem. 284, 29350–29356.
109. Tuplin, A., Wood, J., Evans, D.J., Patel, A.H., and Simmonds, P. (2002). Thermodynamic and phylogenetic prediction of RNA secondary structures in the coding region of hepatitis C virus. RNA 8, 824–841.
110. van den Hoogen, B.G., van Boheemen, S., de Rijck, J., van Nieuwkoop, S., Smith, D.J., Laksono, B., Gultyaev, A., Osterhaus, A.D., Fouchier, R.A. (2014). Excessive production and extreme editing of human metapneumovirus defective interfering RNA is associated with type I IFN induction. J Gen. Virol. 95:1625-1633.
111. Wagner, R.W., Smith, J.E., Cooperman, B.S., and Nishikura, K. (1989). A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs. Proc. Natl. Acad. Sci. U.S.A. 86, 2647–2651.
112. Walsh, E.E., Falsey, A.R., and Sullender, W.M. (1998). Monoclonal antibody neutralization escape mutants of respiratory syncytial virus with unique alterations in the attachment (G) protein. Gen, J. Virol. 79(Pt 3), 479–487.
113. Wang, J.G., Cullen, J., and Lemon, S.M. (1992). Immunoblot analysis demonstrates that the large and small forms of hepatitis delta virus antigen have different C-terminal amino acid sequences. J. Virol. 73(Pt 1), 183-188.
114. Wang, K.S., Choo, Q.L., Weiner, A.J., Ou, J.H., Najarian, R.C., Thayer, R.M., Mullenbach, G.T., Denniston, K.J., Gerin, J.L., and Houghton, M. (1986). Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature 323, 508–514.
115. Ward, S.V., George, C.X., Welch, M.J., Liou, L.Y., Hahm, B., Lewicki, H., de la Torre, J.C., Samuel, C.E., and Oldstone, M.B. (2011). RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. Proc. Natl. Acad. Sci. U.S.A. 108, 331–336.
116. Weiden, M.D., Hoshino, S., Levy, D.N., Li, Y., Kumar, R., Burke, S.A., Dawson, R., Hioe, C.E., Borkowsky, W., Rom, W.N., et al.(2014). Adenosine Deaminase Acting on RNA-1 (ADAR1) Inhibits HIV-1 Replication in Human Alveolar Macrophages. PLoS One 9, e108476.
117. Weiss, R.A. (1993). How does HIV cause AIDS? Science 260, 1273–1279.
118. Wong, S.K., and Lazinski, D.W. (2002). Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1. Proc. Natl. Acad. Sci. U.S.A. 99, 15118–15123.
119. Zahn, R.C., Schelp, I., Utermohlen, O., and von Laer, D. (2007). A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus. J. Virol. 81, 457–464.
120. Zhang, Z., and Carmichael, G.G. (2001). The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell 106, 465–475.